RNAi疗法:扩大对肝外疾病的应用,克服传递挑战
Jong Won Lee1, Man Kyu Shim2, Hyosuk Kim2
1KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.
Advanced drug delivery reviews
|September 1, 2023
概括
RNA干扰 (RNAi) 疗法在治疗遗传疾病方面表现有前途. 需要新的输送系统来准肝脏以外的组织,扩大RNAi治疗应用.
科学领域:
- 生物技术是生物技术.
- 分子医学是分子医学.
- 药物输送系统 药物输送系统
背景情况:
- 使者RNA (mRNA) 疫苗和RNA干扰 (RNAi) 剂标志着RNA医学的成功.
- RNAi疗法提供了向以前无法治疗的疾病基因的潜力.
- 目前的RNAi传递方法,如脂质纳米颗粒 (LNP) 和N-乙银胺 (GalNAc) 结合,主要针对肝脏疾病.
研究的目的:
- 解决尚未满足的RNAi治疗药物的肝外输送需求.
- 讨论将RNAi输送到瘤和其他器官的挑战和临床试验过渡.
- 以突出新型的临床前交付平台,以肝外RNAi为基础的治疗.
主要方法:
- 审查目前RNAi传递系统的进展.
- 用RNAi疗法向肝外组织的挑战分析.
- 探索创新的临床前交付平台.
主要成果:
- 目前的输送系统将RNAi疗法限制在肝脏疾病上.
- 在向瘤和主要器官提供RNAi疗法方面存在重大挑战.
- 有希望的临床前平台正在出现,用于肝外RNAi应用.
结论:
- RNAi传递系统的进化对于向肝外组织至关重要.
- 扩大RNAi疗法指示需要克服输送限制.
- 创新的临床前平台为治疗更广泛的难治性疾病提供了潜力.
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K
Microorganisms in Medicine and Therapeutics
53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Alternative RNA Splicing
21.3K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.3K
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K


